Search - tctmd.com

Displaying 181 - 200 of 247

Sort: Relevancy | Date

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Industry News

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

April 19, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

Presentation Fellows 2019

Case Presentations: Complex Valvular Heart Disease

Presenter: Tamim Nazif

April 14, 2019

Presentation ARCH 2019

Structural Heart Disease - A Peek into the Future

Presenter: Ian T. Meredith

April 11, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Featured Fellow

Philipp Wiesner, MD

Yael L. Maxwell

April 01, 2019

Presentation SIF 2019

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Presenter: Brij Maini

March 30, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Podcast Heart Sounds

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

Presentation ECHO/IMAGING 2019

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

Presenter: Heidi M. Connolly

March 24, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Advertisement

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Case Presentations: Complex Valvular Heart Disease

Structural Heart Disease - A Peek into the Future

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Philipp Wiesner, MD

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Top Stories in Cardiology: March 2019

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content